Pharmaceutical companies have recently appointed themselves experts in the area of women's reproductive health. Not feeling amorous? No problem.   Just pop this pill. Just use this cream.   Pharma ads urge women to reach for the drugs, and end with an image of a happily embracing couple.  Moreover, to really  boost sales, these companies employ both the carrot and the stick: that is, the promise of bliss and the fear of failure.  In addition to guaranteeing instant romance, the companies must persuade consumers that any variation in desire indicates a medical condition. In other words, if you're not always ready for romance, you're suffering from a disease.   Feminist researchers and clinicians have worked diligently to develop innovative ideas about these issues, and offer not only new definitions and descriptions, but have also designed alternative methods for optimizing women's reproductive health.   Our latest online course is authored by Leonore Teifer, Ph.D. and presents research and writing by notable feminist scholars.  Contributors include Leonore Tiefer, Ph.D., Marny Hall, Ph.D., Kathryn Hall, Ph.D., Lisa Aronson Fontes, Ph.D., Marilyn P. Safir, Ph.D., Anna Arroba, Ph.D., and Sadhana Vohra, Ph.D. To access the complete Clinical Update and read more about this topic, click here.  To access our new online course for 6 CE Credits, click here.  Related online courses that critique psychiatry and the pharmaceutical industry: DSM: Diagnosing for Money and Power PsychPharmacology Szasz and the Myth of Mental Illness

Share this:

Follow us on: